Therefore, therapeutic interventions targeting the overexpression of IL-6 and glucose metabolism may serve as a promising strategy to bolster the immune response against viruses mediated by NK cells, particularly in cases where COVID-19 is comorbid with T2D. This evidence concerns the gene IL6 and COVID-19.